search
Back to results

Effects of a 12-week Respiratory Muscles Training Program in Persons With Relapsing- Remitting Multiple Sclerosis

Primary Purpose

Relapsing-remitting Multiple Sclerosis

Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
a 12-week Respiratory Muscles Training Program (RMTP)
Active Comparator
Sponsored by
University of Malaga
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Relapsing-remitting Multiple Sclerosis focused on measuring multiple sclerosis, respiratory muscle strength, maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), respiratory muscle endurance, quality of life, qualitative research

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Males and females older 18 years of age with diagnosis relapsing-remitting multiple sclerosis according to revised McDonald Criteria 2005.
  • Have mild or moderate impairment of gait according to Hauser ambulatory index. The score 1 and 5 will be included (both values inclusive).
  • Subjects who have read, understood, signed and dated the informed consent form.

Exclusion Criteria:

  • Disability caused by other diseases
  • Clinically relevant cognitive or linguistic disorders which are unable to fill in the questionnaires by him/herself
  • Subjects used medication with corticosteroids within the last month (or 30 days) prior to study day 1.
  • Have a recent outbreak (last month) not stabilized prior to inclusion in the study

Sites / Locations

  • University of Málaga

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention group

Control Group

Arm Description

a 12-week respiratory muscles training program (RMTP) with ORYGEN Dual® device and peripheric resistive muscle training program

Peripheric resistive muscle training program and Health Education Program.

Outcomes

Primary Outcome Measures

Maximal inspiratory pressures (MIP) and maximal expiratory pressures (MEP)
Change in respiratory muscle function strength with transducer measuring maximal inspiratory (MIP) and expiratory pressures (MEP)

Secondary Outcome Measures

Pulmonary function test
Pulmonary function test will be performed using spirometer "DATOSPIR 120" according to the Guidelines of American Thoracic Society and the European Respiratory Society.
Handgrip strength
Handgrip strength will be determined using hydraulic hand dynamometer "JAMAR"
Multiple-Sit-to-Stand Test (MSTS)
Lower limb strength using the Multiple-Sit-to-Stand Test (MSTS)
The 12 item MS Walking Scale (MSWS-12)
Walking Capacity using the 12 item MS Walking Scale (MSWS-12)
Timed 25 foot walk (T25FW)
Exercise Capacity using the Shorter timed walking tests with Timed 25 foot walk (T25FW)
Gait analysis
Gait analysis (the Hauser ambulatory index) with which will be assessed the time and effort used by the patient to walk 25 feet (8 meters)
The 54 items Specific Questionnaire Quality of Life Multiple Sclerosis (MSQOL-54)
Change in quality of life using the 54 items Specific Questionnaire Quality of Life Multiple Sclerosis (MSQOL-54)
10 Maximum Resistance (10RM)
Change in endurance of the respiratory muscles with the 10RM manoeuvre
Perceptions Measures
Post interview with participants to qualitatively identify themes of interest and quality of life effects After that the respiratory muscles training program, researchers will interview participants about their interest in carrying out the intervention (difficulties and advantages) and changes in quality of life

Full Information

First Posted
March 27, 2014
Last Updated
April 1, 2014
Sponsor
University of Malaga
search

1. Study Identification

Unique Protocol Identification Number
NCT02104492
Brief Title
Effects of a 12-week Respiratory Muscles Training Program in Persons With Relapsing- Remitting Multiple Sclerosis
Official Title
Clinical Research on the Effect of a 12-week Respiratory Muscles Training Program in Persons With Relapsing-remitting Multiple Sclerosis
Study Type
Interventional

2. Study Status

Record Verification Date
April 2014
Overall Recruitment Status
Unknown status
Study Start Date
March 2014 (undefined)
Primary Completion Date
March 2015 (Anticipated)
Study Completion Date
March 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Malaga

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Multiple sclerosis (MS) is the most common inflammatory demyelinating chronic disease of the central nervous system and the second leading cause of disability in young adults. Motor deficits also involve respiratory muscles. This involvement is present from early stages of disease and is frequently dismissed by professionals until advanced stages of disease. The effect of a training program of respiratory muscles is not sufficiently studied. The aim of this research is to assess the clinical and functional response of a 12-week respiratory muscles training program (RMTP) for persons with relapsing-remitting multiple sclerosis (RRMS). This study is consisted with two sub research: Firstly, a single-blind randomized clinical trial will be carried out in 40 persons with RRMS. Participants either will be received (n = 20) peripheric resistive muscle training program which will be supplemented by a 12-week Respiratory Muscles Training Program (RMTP) with ORYGEN Dual® device for 50 minutes, twice a week during three months or (n = 20) they will be received peripheric resistive muscle training program and health education program. Main outcomes will be strength of the respiratory muscles assessed by maximal inspiratory and expiratory pressure measurements (MIP and MEP). The secondary outcomes will be assessed the quality of life (MSQOL-54), walking speed (T25-FW, MSWS-12 and Hauser ambulatory index), fatigue (MFIS), endurance of the respiratory muscles (10RM) manoeuvre and peripherical muscle strength (Multiple-Sit-to-Stand Test and handgrip strength). Secondly, the qualitative research where researchers will interview participants about their interest in carrying out the intervention (difficulties and advantages) and identify themes of interest about changes in quality of life.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Relapsing-remitting Multiple Sclerosis
Keywords
multiple sclerosis, respiratory muscle strength, maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), respiratory muscle endurance, quality of life, qualitative research

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
a 12-week respiratory muscles training program (RMTP) with ORYGEN Dual® device and peripheric resistive muscle training program
Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
Peripheric resistive muscle training program and Health Education Program.
Intervention Type
Other
Intervention Name(s)
a 12-week Respiratory Muscles Training Program (RMTP)
Other Intervention Name(s)
Intervention Group
Intervention Description
Every session will be lasted 50 minutes and performed under supervision of a physiotherapist. It will be comprised of 30 minutes of progressive aerobic training program followed by peripheric resistive muscle training program which will be supplemented by a 12-week Respiratory Muscles Training Program (RMTP) with ORYGEN Dual® device for 20 minutes. Patients will be instructed to maintain adequate inspiration and expiration while using the Origen-Dual® valve at a rate of 15-20 breaths/minute. Participants will be performed five sets of 10 repetitions followed by 1-2 minutes of unloaded recovery breathing off the device, once a day, 2 days per week, for 12 weeks. The respiratory muscles training will be begun at 30% of MIP achieved at baseline and increased by 5% each week to reach 60% of the baseline assessment MIP.
Intervention Type
Other
Intervention Name(s)
Active Comparator
Other Intervention Name(s)
Control Group
Intervention Description
Every session will be comprised of 30 minutes of progressive aerobic training program followed by peripheric resistive muscle training program and Health Education Program.
Primary Outcome Measure Information:
Title
Maximal inspiratory pressures (MIP) and maximal expiratory pressures (MEP)
Description
Change in respiratory muscle function strength with transducer measuring maximal inspiratory (MIP) and expiratory pressures (MEP)
Time Frame
Baseline and 12 weeks
Secondary Outcome Measure Information:
Title
Pulmonary function test
Description
Pulmonary function test will be performed using spirometer "DATOSPIR 120" according to the Guidelines of American Thoracic Society and the European Respiratory Society.
Time Frame
Baseline and 12 weeks
Title
Handgrip strength
Description
Handgrip strength will be determined using hydraulic hand dynamometer "JAMAR"
Time Frame
Baseline and 12 weeks
Title
Multiple-Sit-to-Stand Test (MSTS)
Description
Lower limb strength using the Multiple-Sit-to-Stand Test (MSTS)
Time Frame
Baseline and 12 weeks
Title
The 12 item MS Walking Scale (MSWS-12)
Description
Walking Capacity using the 12 item MS Walking Scale (MSWS-12)
Time Frame
Baseline and 12 weeks
Title
Timed 25 foot walk (T25FW)
Description
Exercise Capacity using the Shorter timed walking tests with Timed 25 foot walk (T25FW)
Time Frame
Baseline and 12 weeks
Title
Gait analysis
Description
Gait analysis (the Hauser ambulatory index) with which will be assessed the time and effort used by the patient to walk 25 feet (8 meters)
Time Frame
Baseline and 12 weeks
Title
The 54 items Specific Questionnaire Quality of Life Multiple Sclerosis (MSQOL-54)
Description
Change in quality of life using the 54 items Specific Questionnaire Quality of Life Multiple Sclerosis (MSQOL-54)
Time Frame
Baseline and 12 week
Title
10 Maximum Resistance (10RM)
Description
Change in endurance of the respiratory muscles with the 10RM manoeuvre
Time Frame
Baseline, 4 weeks, 8 weeks, 12 weeks.
Title
Perceptions Measures
Description
Post interview with participants to qualitatively identify themes of interest and quality of life effects After that the respiratory muscles training program, researchers will interview participants about their interest in carrying out the intervention (difficulties and advantages) and changes in quality of life
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Males and females older 18 years of age with diagnosis relapsing-remitting multiple sclerosis according to revised McDonald Criteria 2005. Have mild or moderate impairment of gait according to Hauser ambulatory index. The score 1 and 5 will be included (both values inclusive). Subjects who have read, understood, signed and dated the informed consent form. Exclusion Criteria: Disability caused by other diseases Clinically relevant cognitive or linguistic disorders which are unable to fill in the questionnaires by him/herself Subjects used medication with corticosteroids within the last month (or 30 days) prior to study day 1. Have a recent outbreak (last month) not stabilized prior to inclusion in the study
Facility Information:
Facility Name
University of Málaga
City
Málaga
Country
Spain

12. IPD Sharing Statement

Learn more about this trial

Effects of a 12-week Respiratory Muscles Training Program in Persons With Relapsing- Remitting Multiple Sclerosis

We'll reach out to this number within 24 hrs